[1] Watt AH, Stephens MR, Buss DC, et al. Amiodarone reduces plasma warfarin clearance in man[J]. Br J Clin Pharmacol, 1985, 20(6): 707.
[2] Cheung B,Lam FM,Kumana CR.Insidiously evolving, occult drug interaction involving warfarin and amiodarone[J]. BMJ, l996, 312(7023): 107.
[3] Sanoski CA, Bauman JL. Clinical observations with the amiodarone/warfarin interaction[J]. Chest, 2002, 121(1): 19.
[4] Breckenridce A, Orme M. Kinetics of warfarin absorption in man[J].Clin Pharmacol Ther, 1973, 14(6): 955.
[5] Breckenridce A, Orme M, Wesseling H, et a1. Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man[J]. Clin Pharmacol Ther, 1974, 15(4): 424.
[6] 岳林峰.抗凝药物华法林的安全应用[J].药学与临床研究,2009, 17(5): 397.
[7] Habib G,Nashashibi M,Khateeb A,et al.Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room[J].Eur J Intern Med, 2009, 19: 129.
[8] Heimark LD, Wienkers L, Kunze K, et al. The mechanism of the interaction between amiodarone and warfarin in humans[J]. Clin Pharmacol Ther, 1992, 51(4): 398.
[9] Ohyama K, Nakajima M, Suzuki M, et al. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of (in vivo) drug interactions[J]. Br J clin Pharmacol, 2000, 49(3): 244.
[10] 谢 爽,刘 红,娄 莹,等. 胺碘酮对心脏瓣膜置换患者华法林初始服药1周内抗凝效果的研究[J].中国药学杂志, 2010, 45(8): 593.
[11] Walter A, Alexander SG, Ann W, et al. Oral anticoagulant therapy : antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest, 2012, 141: e44S.